Nifedipine induces periostin expression in gingival fibroblasts through TGF-beta

Journal of Dental Research

Volumn 92, Issue 11, 2013, Pages 1022-1028

  Kim, S S ^a   Jackson Boeters, L ^a   Darling, M R ^a   Rieder, M J ^a   Hamilton, D W ^a,b  

^a CHILDREN S HEALTH RESEARCH INSTITUTE   (Canada)

^b WESTERN UNIVERSITY   (Canada)

Author keywords

adverse drug reaction; dihydropyridine; fibrosis; gingival overgrowth; matricellular protein; SMAD3

Indexed keywords

1,3 DIOXOLANE DERIVATIVE; 4 (5 BENZO(1,3)DIOXOL 5 YL 4 PYRIDIN 2 YL 1H IMIDAZOL 2 YL)BENZAMIDE; 4-(5-BENZO(1,3)DIOXOL-5-YL-4-PYRIDIN-2-YL-1H-IMIDAZOL-2-YL)BENZAMIDE; BENZAMIDE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CELL ADHESION MOLECULE; DIHYDROPYRIDINE; NIFEDIPINE; POSTN PROTEIN, HUMAN; SMAD2 PROTEIN; SMAD2 PROTEIN, HUMAN; SMAD3 PROTEIN; SMAD3 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADVERSE DRUG REACTION; ARTICLE; CELL NUCLEUS; CHEMICALLY INDUCED DISORDER; CONNECTIVE TISSUE; CULTURE TECHNIQUE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; EPITHELIUM CELL; FIBROBLAST; FIBROSIS; GINGIVA; GINGIVA OVERGROWTH; HUMAN; MATRICELLULAR PROTEIN; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SMAD3; ULTRASTRUCTURE; UPREGULATION;

ADVERSE DRUG REACTION; DIHYDROPYRIDINE; FIBROSIS; GINGIVAL OVERGROWTH; MATRICELLULAR PROTEIN; SMAD3;

BENZAMIDES; CALCIUM CHANNEL BLOCKERS; CELL ADHESION MOLECULES; CELL CULTURE TECHNIQUES; CELL NUCLEUS; CONNECTIVE TISSUE; DIOXOLES; EPITHELIAL CELLS; FIBROBLASTS; GINGIVA; GINGIVAL OVERGROWTH; HUMANS; NIFEDIPINE; PHOSPHORYLATION; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 84886896185     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034513503659     Document Type: Article

References (29)

1. Arocho A, Chen B, Ladanyi M, Pan Q. Validation of the 2-DeltaDeltaCt calculation as an alternate method of data analysis for quantitative PCR of BCR-ABL P210 transcripts. Diagn Mol Pathol. 2006 ; 15: 56-61
2. Barclay S, Thomason JM, Idle JR, Seymour RA. The incidence and severity of nifedipine-induced gingival overgrowth. J Clin Periodontol. 1992 ; 19: 311-314
3. Bonniaud P, Kolb M, Galt T, Robertson J, Robbins C, Stampfli M, et al. Smad3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis. J Immunol. 2004 ; 173: 2099-2108
4. Bornstein P, Sage EH. Matricellular proteins: extracellular modulators of cell function. Curr Opin Cell Biol. 2002 ; 14: 608-616
5. Brown RS, Beaver WT, Bottomley WK. On the mechanism of drug-induced gingival hyperplasia. J Oral Pathol Med. 1991 ; 20: 201-209
6. Brunette DM, Kenner GS, Gould TR. Grooved titanium surfaces orient growth and migration of cells from human gingival explants. J Dent Res. 1983 ; 62: 1045-1048
7. Chen SJ, Yuan W, Mori Y, Levenson A, Trojanowska M, Varga J. Stimulation of type I collagen transcription in human skin fibroblasts by TGF-beta: involvement of Smad 3. J Invest Dermatol. 1999 ; 112: 49-57
8. Elliott CG, Hamilton DW. Deconstructing fibrosis research: do pro-fibrotic signals point the way for chronic dermal wound regeneration?. J Cell Commun Signal. 2011 ; 5: 301-315
9. Elliott CG, Wang J, Guo X, Xu SW, Eastwood M, Guan J, et al. Periostin modulates myofibroblast differentiation during full-thickness cutaneous wound repair. J Cell Sci. 2012 ; 125 (Pt 1). 121-132
10. Hamilton DW. Functional role of periostin in development and wound repair: implications for connective tissue disease. J Cell Commun Signal. 2008 ; 2: 9-17
11. Hirani R, Hanssen E, Gibson MA. LTBP-2 specifically interacts with the amino-terminal region of fibrillin-1 and competes with LTBP-1 for binding to this microfibrillar protein. Matrix Biol. 2007 ; 26: 213-223
12. Jackson-Boeters L, Wen W, Hamilton DW. Periostin localizes to cells in normal skin, but is associated with the extracellular matrix during wound repair. J Cell Commun Signal. 2009 ; 3: 125-133
13. Jeng JH, Lan WH, Wang JS, Chan CP, Ho YS, Lee PH, et al. Signaling mechanism of thrombin-induced gingival fibroblast-populated collagen gel contraction. Br J Pharmacol. 2006 ; 147: 188-198
14. Miranda J, Brunet L, Roset P, Berini L, Farre M, Mendieta C. Prevalence and risk of gingival enlargement in patients treated with nifedipine. J Periodontol. 2001 ; 72: 605-611
15. Naik PK, Bozyk PD, Bentley JK, Popova AP, Birch CM, Wilke CA, et al. Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2012 ; 303: L1046-1056
16. Norris RA, Borg TK, Butcher JT, Baudino TA, Banerjee I, Markwald RR. Neonatal and adult cardiovascular pathophysiological remodeling and repair: developmental role of periostin. Ann NY Acad Sci. 2008 ; 1123: 30-40
17. Ono RN, Sengle G, Charbonneau NL, Carlberg V, Bachinger HP, Sasaki T, et al. Latent transforming growth factor beta-binding proteins and fibulins compete for fibrillin-1 and exhibit exquisite specificities in binding sites. J Biol Chem. 2009 ; 284: 16872-16881
18. Padial-Molina M, Volk SL, Taut AD, Giannobile WV, Rios HF. Periostin is down-regulated during periodontal inflammation. J Dent Res. 2012 ; 91: 1078-1084
19. Saito K, Mori S, Iwakura M, Sakamoto S. Immunohistochemical localization of transforming growth factor beta, basic fibroblast growth factor and heparan sulphate glycosaminoglycan in gingival hyperplasia induced by nifedipine and phenytoin. J Periodontal Res. 1996 ; 31: 545-555
20. Sorkin EM, Clissold SP, Brogden RN. Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders. Drugs. 1985 ; 30: 182-274
21. Sousa CP, Navarro CM, Sposto MR. Clinical assessment of nifedipine-induced gingival overgrowth in a group of Brazilian patients. ISRN Dent. 2011 ; 2011: 102047
22. Tavassoli S, Yamalik N, Caglayan F, Caglayan G, Eratalay K. The clinical effects of nifedipine on periodontal status. J Periodontol. 1998 ; 69: 108-112
23. Thomason JM, Ellis JS, Kelly PJ, Seymour RA. Nifedipine pharmacological variables as risk factors for gingival overgrowth in organ-transplant patients. Clin Oral Investig. 1997 ; 1: 35-39
24. Tipton DA, Fry HR, Dabbous MK. Altered collagen metabolism in nifedipine-induced gingival overgrowth. J Periodontal Res. 1994 ; 29: 401-409
25. Uzel MI, Kantarci A, Hong HH, Uygur C, Sheff MC, Firatli E, et al. Connective tissue growth factor in drug-induced gingival overgrowth. J Periodontol. 2001 ; 72: 921-931
26. Wang W, Huang XR, Canlas E, Oka K, Truong LD, Deng C, et al. Essential role of Smad3 in angiotensin II-induced vascular fibrosis. Circ Res. 2006 ; 98: 1032-1039
27. Wen W, Chau E, Jackson-Boeters L, Elliott C, Daley TD, Hamilton DW. TGF-beta 1 and FAK regulate periostin expression in PDL fibroblasts. J Dent Res. 2010 ; 89: 1439-1443
28. Yamaguchi Y, Ono J, Masuoka M, Ohta S, Izuhara K, Ikezawa Z, et al. Serum periostin levels are correlated with progressive skin sclerosis in patients with systemic sclerosis. Br J Dermatol. 2012 ; 168: 717-725
29. Zhou HM, Wang J, Elliott C, Wen W, Hamilton DW, Conway SJ. Spatiotemporal expression of periostin during skin development and incisional wound healing: lessons for human fibrotic scar formation. J Cell Commun Signal. 2010 ; 4: 99-107